{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:57:26Z","timestamp":1780981046615,"version":"3.54.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Children living with HIV are experiencing rising rates of obesity, driven by both the side effects of antiretroviral therapy and the increasingly obesogenic environments. Obesity and HIV are both known to cause immune dysregulation, which may have a combined negative effect on vaccine-induced immune response in this vulnerable population. This study aimed to determine whether body mass index z-score (BMIz) is associated with vaccine-induced antibody concentrations in children living with HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study used data from clinical trials for 3 separate vaccines (hepatitis A, hepatitis B and pneumococcal [conjugate plus polysaccharide]) administered to children living with HIV. Enrollment was between September 1999 and March 2003 in the United States. Adjusted linear regression for interval-censored data and logistic regression models were used to assess associations for BMIz with antibody response up to 104 weeks after vaccine administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Participant age ranged from 2 to 20 years old. Analyses included 150 participants for the hepatitis A vaccine, 154 for the hepatitis B vaccine and 214 for the pneumococcal vaccine. BMIz was associated with hepatitis B antibody concentration 8 weeks after vaccination (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.026) with the highest probability (47%) of seroconversion for participants with BMIz near 1. There was no statistically significant association between BMIz and antibody response for the hepatitis A vaccine or 4 of 5 studied serotypes in the pneumococcal vaccine (n = 214).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The hepatitis A, hepatitis B and pneumococcal vaccines are likely adequate as administered and protective for children living with HIV at a broad range of BMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005153","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:00:28Z","timestamp":1769576428000},"page":"649-654","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Body Mass Index and Vaccine-induced Immune Responses in Children Living With HIV"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4971-9585","authenticated-orcid":false,"given":"Jacob D.","family":"Massa","sequence":"first","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Giganti","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Lindsey","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron J.","family":"Levin","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3419-9471","authenticated-orcid":false,"given":"Sharon","family":"Nachman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, Renaissance School of Medicine at Stony Brook, Stony Brook, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"R1-20260609","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2015.06.101","article-title":"The weight of obesity on the human immune response to vaccination.","volume":"33","author":"Painter","year":"2015","journal-title":"Vaccine"},{"key":"R2-20260609","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10096-015-2558-8","article-title":"Obesity: impact of infections and response to vaccines.","volume":"35","author":"Tagliabue","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R3-20260609","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/QAD.0000000000003281","article-title":"Obesity in HIV infection: host-pathogen interaction.","volume":"36","author":"Savinelli","year":"2022","journal-title":"AIDS"},{"key":"R5-20260609","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ijo.2011.208","article-title":"Obesity is associated with impaired immune response to influenza vaccination in humans.","volume":"36","author":"Sheridan","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"R6-20260609","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/21645515.2016.1274475","article-title":"Influences of obesity on the immunogenicity of hepatitis B vaccine.","volume":"13","author":"Liu","year":"2017","journal-title":"Hum Vacci Immunother"},{"key":"R7-20260609","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0264-410X(95)00176-2","article-title":"Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination.","volume":"14","author":"Sim\u00f3 Mi\u00f1ana","year":"1996","journal-title":"Vaccine"},{"key":"R8-20260609","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1001\/jama.1993.03510240043029","article-title":"Hepatitis B vaccine responsiveness in Connecticut public safety personnel.","volume":"270","author":"Roome","year":"1993","journal-title":"JAMA"},{"key":"R9-20260609","first-page":"983","article-title":"Hepatitis B vaccination in pregnancy: factors influencing efficacy.","volume":"93","author":"Ingardia","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R10-20260609","doi-asserted-by":"crossref","first-page":"c89","DOI":"10.1159\/000092016","article-title":"Antibody response to hepatitis B vaccine in end-stage renal disease patients.","volume":"103","author":"Chow","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"R11-20260609","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.vaccine.2006.04.016","article-title":"Hepatitis A\/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.","volume":"24","author":"Van der Wielen","year":"2006","journal-title":"Vaccine"},{"key":"R12-20260609","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41467-022-28527-x","article-title":"Population antibody responses following COVID-19 vaccination in 212,102 individuals.","volume":"13","author":"Ward","year":"2022","journal-title":"Nat Commun"},{"key":"R13-20260609","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.vaccine.2013.12.019","article-title":"Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students.","volume":"32","author":"Banga","year":"2014","journal-title":"Vaccine"},{"key":"R14-20260609","doi-asserted-by":"crossref","first-page":"e103446","DOI":"10.1371\/journal.pone.0103446","article-title":"Predictors of HVTN 503 MRK-AD5 HIV-1 gag\/pol\/nef vaccine induced immune responses.","volume":"9","author":"Hopkins","year":"2014","journal-title":"PLoS One"},{"key":"R15-20260609","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/MOP.0000000000000953","article-title":"Obesity and immune status in children.","volume":"32","author":"Fang","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"R16-20260609","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1016\/j.vaccine.2019.09.089","article-title":"The immune response to a two-dose schedule of quadrivalent HPV vaccine in 9-13 year-old girls: is it influenced by age, menarche status or body mass index?","volume":"37","author":"Sauvageau","year":"2019","journal-title":"Vaccine"},{"key":"R17-20260609","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08916930600597326","article-title":"Reduced tetanus antibody titers in overweight children.","volume":"39","author":"Eliakim","year":"2006","journal-title":"Autoimmunity"},{"key":"R18-20260609","doi-asserted-by":"crossref","first-page":"AB299","DOI":"10.1016\/j.jaci.2018.12.913","article-title":"Can obesity alter the immune response to childhood vaccinations?","volume":"143","author":"Huang","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R19-20260609","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/vaccines9020130","article-title":"Impact of obesity and being overweight on the immunogenicity to live attenuated hepatitis: a vaccine in children and young adults.","volume":"9","author":"Dumrisilp","year":"2021","journal-title":"Vaccines"},{"key":"R20-20260609","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAI.0b013e318203e9f2","article-title":"Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.","volume":"56","author":"Flynn","year":"2011","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"R21-20260609","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11904-020-00483-5","article-title":"Obesity and weight gain in persons with HIV.","volume":"17","author":"Bailin","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R22-20260609","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/09540121.2020.1770181","article-title":"Changes in body mass index among people living with HIV who are new on highly active antiretroviral therapy: a systematic review and meta-analysis.","volume":"33","author":"Olawepo","year":"2021","journal-title":"AIDS Care"},{"key":"R23-20260609","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/jac\/dky145","article-title":"Obesity following ART initiation is common and influenced by both traditional and HIV-\/ART-specific risk factors.","volume":"73","author":"Bakal","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R24-20260609","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1542\/peds.114.2.e235","article-title":"Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens.","volume":"114","author":"Taylor","year":"2004","journal-title":"Pediatrics"},{"key":"R25-20260609","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12981-024-00615-6","article-title":"Prevalence of overweight and obesity among adolescents living with HIV after dolutegravir-based antiretroviral therapy start in Kampala, Uganda.","volume":"21","author":"Nakatudde","year":"2024","journal-title":"AIDS Res Ther"},{"key":"R26-20260609","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/QAI.0b013e31824330cb","article-title":"Body fat abnormality in HIV-infected children and adolescents living in Europe.","volume":"59","author":"Alam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-20260609","doi-asserted-by":"crossref","first-page":"e0266637","DOI":"10.1371\/journal.pone.0266637","article-title":"Multilevel correlates of abdominal obesity in adolescents and youth living with HIV in peri-urban Cape Town, South Africa.","volume":"18","author":"Kamkuemah","year":"2023","journal-title":"PLoS One"},{"key":"R29-20260609","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/498979","article-title":"Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.","volume":"193","author":"Weinberg","year":"2006","journal-title":"J Infect Dis"},{"key":"R30-20260609","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1086\/605448","article-title":"Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.","volume":"200","author":"Abzug","year":"2009","journal-title":"J Infect Dis"},{"key":"R31-20260609","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.inf.0000237830.33228.c3","article-title":"Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.","volume":"25","author":"Abzug","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20260609","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1002\/1097-0258(20001215)19:23<3171::AID-SIM619>3.0.CO;2-T","article-title":"Analysis and design issues for studies using censored biomarker measurements with an example of viral load measurements in HIV clinical trials.","volume":"19","author":"Hughes","year":"2000","journal-title":"Stat Med"},{"key":"R33-20260609","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.cpnec.2021.100052","article-title":"How to deal with non-detectable and outlying values in biomarker research: best practices and recommendations for univariate imputation approaches.","volume":"7","author":"Herbers","year":"2021","journal-title":"Compr Psychoneuroendocrinol"},{"issue":"Suppl 2","key":"R34-20260609","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1093\/infdis\/jiad285","article-title":"Statistical challenges when analyzing SARS-CoV-2 RNA measurements below the assay limit of quantification in COVID-19 clinical trials.","volume":"228","author":"Moser","year":"2023","journal-title":"J Infect Dis"},{"key":"R36-20260609","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/QAI.0000000000001221","article-title":"Brief report: assessing and interpreting the association between continuous covariates and outcomes in observational studies of HIV Using Splines.","volume":"74","author":"Shepherd","year":"2016","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"R38-20260609","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4103\/jfmpc.jfmpc_596_23","article-title":"Vaccine and malnutrition: a narrative review.","volume":"12","author":"Tripathy","year":"2023","journal-title":"J Family Med Prim Care"},{"key":"R39-20260609","doi-asserted-by":"crossref","first-page":"126564","DOI":"10.1016\/j.vaccine.2024.126564","article-title":"Undernutrition and antibody response to measles, tetanus and Haemophilus influenzae type b (HiB) vaccination in pre-school South African children: the VHEMBE birth cohort study.","volume":"46","author":"Eskenazi","year":"2025","journal-title":"Vaccine"},{"key":"R40-20260609","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/INF.0000000000003206","article-title":"Rotavirus infection, illness, and vaccine performance in malnourished children: a review of the literature.","volume":"40","author":"Burnett","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R41-20260609","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bcp.12403","article-title":"The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.","volume":"79","author":"Tseng","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R42-20260609","article-title":"Prevalence of overweight, obesity, and severe obesity among children and adolescents aged 2\u201319 years: United States, 1963\u20131965 through 2017\u20132018.","author":"Fryar","year":"2020","journal-title":"NCHS Health E-Stats"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:00:57Z","timestamp":1780977657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005153","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}